Telesis Bio, Inc. engages in the provision of automated multi-omic and synthetic biology solutions. The firm also focuses on providing applications to enable researchers to rapidly, accurately, and reproducibly build or write synthetic DNA and mRNA and short oligonucleotides such as CRISPR guides that are ready to use in many downstream synthetic biology enabled markets. The company was founded by Daniel G. Gibson and J. Craig Venter on March 24, 2011 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Telesis Bio Inc market cap is $784,078.00.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Telesis Bio Inc 52 week high is $0.15 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Telesis Bio Inc 52 week low is $0.0001 as of November 18, 2026.
Telesis Bio Inc stock price today is $0.01.
Telesis Bio Inc stock price yesterday was $0.01.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Telesis Bio Inc 50-day moving average is $0.0133.